menu
more_vert
Home / Reports / Glucagon Market

Global Glucagon Market By Type (Inject Glucagon, and Nasal Glucagon), By Application (Emergency Kits, General Use, and Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028

  • account_circleAbout Me
    • 19431
    • $3,495.00
    • $5,100.00
    • $7,200.00
    Buy Now

    The report on Glucagon Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global glucagon market is segmented on the basis of type, application and geography.

    The Global Glucagon Market was valued at US$ 451.2 Mn in 2018 and is projected to increase significantly at a CAGR of 6.3% from 2019 to 2028.

    Glucagon Market Scope:

    By type, the market is segmented into Inject Glucagon and Nasal Glucagon. By application, the market is divided into Emergency Kits, General Use, Diagnostic & Motility and Cardiogenic Shock. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals.

    trending_up Total Revenue in 2018

    $451.2 Mn

    trending_up Market CAGR of the Next Ten Years

    6.3%

    no_encryption Market Value (US$ Mn), Share (%) and Growth Rate (%) Comparison 2012-2028
    Purchase this report or a membership to unlock the market value (US$ Mn), share (%) and growth rate (%) comparison for this industry.
    • By Type
    • By Region
    • By Application
    no_encryption Leading Companies Financial Highlights
    Purchase this report or a membership to unlock the leading companies financial highlights for this industry.

    trending_up Market Revenue of the Next Ten Years

    $XXXX Mn

    Key Market Segments:

    Type

    • Inject Glucagon
    • Nasal Glucagon

    Application

    • Emergency Kits
    • General Use
    • Diagnostic & Motility
    • Cardiogenic Shock

    Key Market Players included in the report:

    • Novo Nordisk
    • Eli Lilly
    • Fresenius Kabi
    • Torrent Labs
    • Taj Pharmaceuticals
    • Xeris Pharmaceuticals

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis - industry research (global industry trends) and Glucagon Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Glucagon Market, high-growth regions, and market drivers, restraints and also market chances.

    The analysis covers Glucagon Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Glucagon Market across sections such as also application and representatives.

    Additionally, the analysis also has a comprehensive review of the crucial players on the Glucagon Market together side their company profiles, SWOT analysis, latest advancements and business plans.

    The analysis objectives of the report are:

    • To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
    • To know the Glucagon Market by pinpointing its many subsegments.
    • To profile the important players and analyze their growth plans.
    • To endeavor the amount and value of Glucagon sub-markets, depending on key regions (various vital states).
    • To analyze Glucagon Market concerning growth trends, prospects and also their participation in the entire sector.
    • To examine and study the Glucagon Market size (volume & value) from the company, essential regions/countries, products and application, background information from 2012 to 2018 and also prediction to 2028.
    • Primary worldwide Glucagon Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    • To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

    For the Glucagon Market research study, the following years have been considered to estimate the market size:

    ParticularScope
    Region

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East and Africa

    Historic Year2012 to 2017
    Estimated Year2018
    Forecast Year2019 to 2028

    Glucagon Market

    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
    • 19431
    • $3,495.00
    • $5,100.00
    • $7,200.00
    Buy Now
    • 1. Glucagon Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Glucagon Market Overview
      • 3.1. Glucagon Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Glucagon Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Glucagon Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Inject Glucagon
      • 4.4. Nasal Glucagon
    • 5. Global Glucagon Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Glucagon Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Emergency Kits
      • 5.4. General Use
      • 5.5. Diagnostic & Motility
      • 5.6. Cardiogenic Shock
    • 6. Global Glucagon Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Glucagon Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2. Europe
        • 6.2.1. Europe Glucagon Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Glucagon Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Glucagon Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Glucagon Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Glucagon Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Novo Nordisk
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Eli Lilly
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Fresenius Kabi
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Torrent Labs
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Taj Pharmaceuticals
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Xeris Pharmaceuticals
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
  • ondemand_videoVideos
    • 19431
    • $3,495.00
    • $5,100.00
    • $7,200.00
    Buy Now
    • Novo Nordisk
    • Eli Lilly
    • Fresenius Kabi
    • Torrent Labs
    • Taj Pharmaceuticals
    • Xeris Pharmaceuticals
  • settingsSettings

Our Clients

Subscribe

Subscribe Now

Request for Sample

  • 19431
  • $3,495.00
  • $5,100.00
  • $7,200.00
Buy Now

Find Help

Legal

Explore

Secured Payment Options

PayPal Payment System
Payoneer Payment System